Matteo Ziacchi, EHRA 2019 – Left Ventricular Endocardial Stimulation
At EHRA 2019 in Lisbon, Matteo Ziacchi (Cardiologist, Sant’Orsola-Malphighi Polyclinic, Bologna, Italy) joins us to discuss the benefits of the emerging cardiac resynchronisation therapy and the key findings from his recent study.
Filmed at EHRA 2019, Lisbon.
Speaker’s Disclosures: Dr Matteo Ziacchi is associated with Biotronik, Boston Scientific and Medronic.
Questions:
- Cardiac resynchronisation therapy is evolving – can you summarise the left ventricular lead options available to physicians? (0:14)
- Can you describe the potential benefits of the active fixation quadripolar left ventricular lead? (1:00)
- Why is it important to have technology that reduces risk of phrenic nerve stimulation? (1:55)
- What were the key findings of your recent study, and how might they improve routine cardiac resynchronisation therapy? (2:38)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
